Our study aims to characterize the expression patterns of Cx43 and Cx40 in the placenta with and without chorioamnionitis, and to correlate their expression with the severity of chorioamnionitis and adverse perinatal outcomes. The gene discussed is GJA5; the disease is chorioamnionitis.